| Financial Year |
March 31 2023 |
| Monetary Funds |
463,738,402.99 |
| Held-for-trading Financial Assets |
10,000,000.00 |
| Notes Receivable |
7,499,204.80 |
| Accounts Receivable |
1,606,712,244.02 |
| Advances to Suppliers |
105,719,557.98 |
| Other Receivables |
98,379,653.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
626,110,667.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
57,341,998.88 |
| Other Current Assets |
100,764,961.95 |
| Total Current Assets |
3,712,628,190.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
71,412,711.83 |
| Long-term Equity Investment |
46,050,340.83 |
| Investment Properties |
69,952,060.94 |
| Fixed Assetes |
370,810,017.89 |
| Under-construction Projects |
581,570.03 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,473,303,061.50 |
| R&D expenses |
-- |
| Goodwill |
1,151,860,887.90 |
| Long-Term Deferred and Prepaid Expenses |
3,139,251.98 |
| Deferred Income Tax Assets |
274,236,640.32 |
| Other Non-Current Assets |
194,854,252.23 |
| Sub-Total of Non-Current Assets |
3,663,859,501.62 |
| Total Assets |
7,376,487,692.07 |
| Short-Term Loans |
780,122,210.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
97,619,553.50 |
| Accounts Payable |
1,225,607,718.86 |
| Accounts Received In Advance |
3,585,657.21 |
| Employee Compensation Payable |
18,989,204.35 |
| Taxes Payable |
34,301,119.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
118,751,818.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
250,740,606.77 |
| Other Current Liabilities |
21,206,239.36 |
| Sub-Total of Current Liabilities |
2,749,113,309.29 |
| Long-term Loans |
36,829,769.44 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
221,813,641.53 |
| Special Payable |
-- |
| Estimatied Liabilities |
123,895.90 |
| Deferred Income Tax Liabilities |
8,426,527.39 |
| Other Non-Current Liabilities |
1,004,369.78 |
| Sub-Total of Non-Current Liabilities |
277,836,892.68 |
| Total Liabilities |
3,026,950,201.97 |
| Paid-In Capital(Or Share Stock) |
740,110,901.00 |
| Capital Surplus |
3,116,236,772.33 |
| Surplus Reserve |
57,381,022.02 |
| LESS:Treasury Stock |
150,033,637.57 |
| Undistributed Profits |
425,419,971.67 |
| Minority Stockholder's Interest |
169,347,460.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,180,190,029.45 |
| Owner's Equity（Stockholder's Equity） |
4,349,537,490.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,376,487,692.07 |
